Antioxidants and heart transplant
This article was originally published in The Tan Sheet
Executive Summary
Vitamin C, E supplementation retards progression of post-transplant artery disease, Dominik Behrendt, Brigham & Women's Hospital, Boston, et al., state in ACC meeting presentation. In a double-blind, prospective study, 35 cardiac transplantation patients were randomized to either placebo or combined vitamin C/E for one year. Vessel function was assessed at baseline and after treatment. "Antioxidant vitamins prevent progression of [transplant-associated ateriopathy] especially in patients at high risk with endothelial dysfunction at baseline," researchers affirm
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning